Event Highlights
News from Bayer
February 06, 2023
Not intended for U.S. and UK Media
Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU
February 02, 2023
Bayer and Kimitec join forces to bring the next generation of Biologicals to millions of growers worldwide
Discover More Investor Resources